|
|
| Countries covered: United States Research Overview This Frost & Sullivan research service entitled U.S. RNAi Markets provides revenue forecasts for individual market sectors as well as overall market, detailed market trends with specific applications forecasts, and market-wide challenge with corresponding strategic recommendations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: Total RNAi Market, RNAi Content Market, RNAi Delivery Tools Market, and RNAi Screening and Analysis Tools Markets. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
The following technologies are covered in this research:
The U.S. RNAi markets are rapidly evolving as a growing number of scientists transition their research focus from low-throughput to medium- and high-throughput in one dimension, and from in vitro to in vivo in a second dimension. Numerous opportunities exist for vendors of RNAi content and tools, especially as technologies advance to provide greater selectivity and specificity of knockdown. RNAi technologies are proving to be indispensable tools for functional genomics research and for identifying and validating potential drug targets. RNAi has become a vital tool for examining both gene and protein expression analyses, especially with regards to understanding the pre- and post-transcriptional function of genes in relation to disease. Using RNAi, researchers are able to simply turn genes on and off and observe what happens, thereby gaining insights into how genes participate in cellular processes. RNAi is by far the most widely used gene-silencing technique employed in research. The Frost & Sullivan study on U.S. RNAi markets provides a detailed examination of both quantitative aspects of the market and qualitative RNAi research trends. With thorough analyses of the transition to in vivo research and the shift towards high-throughput research, the study forecasts future revenues as well as future applications of various RNAi technologies. Furthermore, the study segments the market in an innovative way with market drivers, market restraints, technology trends, market trends, revenue forecasts, competitive landscape analyses, and market share analyses for the RNAi content market, RNAi delivery tools market, and RNAi screening and analysis tools market. This Frost & Sullivan study offers forecasts through 2012 concerning RNAi-related technologies such as siRNA, shRNA, miRNA, transfection reagents, electroporation devices, viral vectors, nanoparticle agents, gene expression assays, protein assays, and phenotypic assays. |
More United States Drug Delivery Reports
Freedonia Focus on Implantable Medical Devices: United States by
Freedonia Focus
This report discusses US demand for implantable medical devices for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product ...
Implantable Medical Devices by
Freedonia Group Inc
US demand to increase 7.7% annually through 2015 US demand for implantable medical devices will increase 7.7 percent annually to $52 billion in 2015. These ...
Freedonia Focus on Drug Delivery Products: United States by
Freedonia Focus
This report discusses US drug delivery products demand for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product and ...
Drug Delivery Systems by
Freedonia Group Inc
US demand to rise 7.2% annually through 2015 US demand for drug delivery products is forecast to expand 7.2 percent annually to $133 billion in ...
US Market for Implantable Medical Devices by
Taiyou Research
It is expected that the demand for implantable medical devices in the United States will increase by nearly 8.5 percent by 2015. Although weakened in ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
- Biotechnology
- Antisense & RNAi Technology
- Life Sciences
- Pharmaceuticals
- Pharmaceuticals
- Drug Delivery
Drug Delivery Reports
- Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
- Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
- Implantable Medical Devices
- Global Inhaled Antibiotics Market 2011-2015
- Drug Delivery: Surveying the Global Competitive Landscape

